What does the academic evidence really show about Ethereum?
The latest SAIMSARA review explores scientific findings on blockchain security, smart-contract vulnerabilities, gas fees, fraud detection, MEV, censorship, DeFi, NFTs, scalability, privacy, governance, and real-world applications.
Bringing together 250 references and 488 original studies, it provides the largest consolidated academic evidence summary on Ethereum in one place.
Read the full paper and explore the complete evidence map:
https://t.co/iLyd4ifK2P
#Ethereum #Blockchain #SmartContracts #DeFi #CryptoResearch #BlockchainSecurity #MEV #NFT #Web3 #Cryptocurrency #EvidenceBased #ScopingReview #SAIMSARA
How can AI help prevent vision loss?
Latest MLHS paper by Molchanov & Pal demonstrates a DenseNet201 framework achieving 97% accuracy in classifying retinal diseases from OCT scans.
Read the full study:
https://t.co/KAVF2gnlXk
#AI#DeepLearning#Ophthalmology#DigitalHealth
I’m not a Trump supporter, and I don’t even live in the US—but $TRUMP made me think.
Every major politician should have a public token. Not as a replacement for elections, but as a real-time market signal of attention, and willingness to stand behind a political figure.
#Crypto
Indeed. Energy is concentrated potential, ready to be unleashed. In life science, we are building its equivalent: machine-readable science—rocket fuel for accelerating human longevity, health, and well-being.
Fear of missing out (FOMO) is more than a social-media habit.
This scoping review maps how FOMO relates to mental health, sleep, problematic digital use, impulsive buying, investment decisions, workplace strain, and risk behavior.
The evidence map was built from 351 references, 722 original studies, and 313,672 topic-deduplicated participant/sample observations.
Read the full SAIMSARA scoping review and explore the complete evidence map:
https://t.co/tf147WXUdB
#FOMO #MentalHealth #SocialMedia #Psychology #BehavioralScience #ScopingReview #SAIMSARA
🅔🅧🅞🅢🅚🅔🅛🅔🅣🅞🅝🅢
Medical and industrial human augmentation has become a reality, and the evidence base is growing at enormous speed.
We mapped it in a review with more than 1,000 linked references, available both as a full read and as machine-readable JSON for AI/LLM workflows:
https://t.co/hSR3H0auMX
#Exoskeletons #WearableRobotics #Rehabilitation #HumanAugmentation #OccupationalHealth #AssistiveTechnology #AIinMedicine #LLM #MachineReadable #EvidenceMapping #SAIMSARA
Why are synthesized SAIMSARA papers not free?
SAIMSARA papers are not copied PDFs or traditional articles stored somewhere on the internet. They are newly generated evidence syntheses created inside the SAIMSARA workflow.
In its current architecture, SAIMSARA uses API access to several major LLM models, including Gemini, Grok, ChatGPT, Claude, and DeepSeek. Each synthesized paper, deep evidence synthesis, and Pro generation consumes paid tokens. That is why full synthesized papers cannot be offered for free: behind every result there are real computational costs.
At the same time, the price of generation is far lower than the human labor required to collect the same evidence manually. Anyone who has ever searched scientific literature on a specific topic knows that even reference collection alone can take days, weeks, or sometimes months.
When you purchase a SAIMSARA paper, you are buying back your time.
🅒🅡🅨🅟🅣🅞 is not only finance — it is also a public health topic.
In this short video, we discuss both sides from our SAIMSARA review: trading-related mental health risks, gambling-like behavior, mining pollution, and the potential of blockchain for healthcare data and governance.
Watch here:
https://t.co/Z9CJSjz9kr
#Cryptocurrency #PublicHealth #Blockchain #MentalHealth #Healthcare #SAIMSARA
Remote robotic surgery is no longer science fiction. 🤖🏥
A new SAIMSARA video breaks down 3 key signals from a review of 207 original studies and >4,300 participants/sample observations.
The evidence suggests that 5G telesurgery can be clinically feasible across distances >1,700 km — but only when latency, redundancy, cybersecurity, and haptic feedback are treated as clinical safety infrastructure.
https://t.co/qiQvAGMOl0
#Telesurgery #5G #RoboticSurgery #MedTech #DigitalHealth #Surgery
🅐🅘 🅒🅗🅐🅣🅑🅞🅣 🅐🅓🅓🅘🅒🅣🅘🅞🅝, attachment, and emotional dependency.
Rare topic, high impact.
☸️SAIMSARA Digital found only 20 original studies with 6k+ participants — but the signal matters: loneliness, perceived empathy, parasocial bonds, and overreliance.
Read the evidence map + vote on AI trust:
https://t.co/pLWYnNmFGH
#SAIMSARA #DigitalHealth #AIChatbots #AIEthics #MentalHealth
Can AI really act as a CEO?
This short video highlights 3 evidence-based facts: AI can draft executive messages, support decisions, and simulate crisis responses — but trust, accountability, and legitimacy remain human problems.
Watch here:
https://t.co/eW1I1LPPAM
#AIasCEO #ArtificialIntelligence #ExecutiveLeadership #AIGovernance #CorporateGovernance #SAIMSARA
ChatGPT vs Claude is the wrong question.
In digital health, the real question is: which model, for which task, under which risk?
One LLM may win in imaging. Another in education, coding, safety, or research workflows. The winner changes with modality, endpoint, version, and governance pressure.
SAIMSARA turns the noise into an evidence map:
156 references · 519 original research papers
Built for humans. Structured for machines.
https://t.co/XVSiw4TEAS
#DigitalHealth #AIinMedicine #ChatGPT #Claude #LLM #EvidenceMap #MachineReadableScience #SAIMSARA
Digital health is not only about tracking physiology — it is also about how medical evidence travels.
Our new SAIMSARA evidence map compares LinkedIn vs Twitter/X across healthcare, academia, business, government, and computational research: where each platform works, where it fails, and how evidence should be distributed to humans and machines.
Read the synthesis or use the structured JSON feed for your LLM.
https://t.co/1cjqMwhDZ1
#DigitalHealth #EvidenceSynthesis #MedicalAI #LinkedIn #Twitter #X #LLM #SAIMSARA
@jason_mayes@Google This is exactly the right direction: orchestrator-worker design can reduce risk by limiting privileges. But the stronger layer is traceability: human-verified, machine-readable evidence objects with source metadata, DOI, license information in JSON-LD, and an audit trail.
🅐🅘-🅖🅔🅝🅔🅡🅐🅣🅔🅓 🅥🅞🅘🅒🅔 is no longer just synthetic speech — it is becoming realistic enough for education, healthcare, accessibility, media, and commerce.
But the same realism creates a safety gap: humans may detect synthetic voices poorly, while automated detectors can exceed 99% only in constrained settings.
Our new SAIMSARA scoping review maps 226 original studies into a structured human- and machine-readable evidence map covering voice cloning, synthetic speech, deepfake detection, authentication, and provenance.
https://t.co/8SWyfDtNeA
#AIVoice #VoiceCloning #SyntheticSpeech #DeepfakeDetection #DigitalHealth #AIResearch #SAIMSARA
Scientific papers were written for humans.
But AI agents do not need another PDF.
They need structured, citation-linked evidence they can immediately reason with.
SAIMSARA turns scientific literature into machine-readable evidence objects — so your LLM, RAG system, or research agent can transform the evidence into the format you actually need.
Not just a paper.
🅔🅥🅘🅓🅔🅝🅒🅔 as 🅙🅢🅞🅝
#AI #LLM #RAG #ScientificPublishing #MachineReadableEvidence #EvidenceAPI #DigitalHealth #MedicalAI #SAIMSARA
Another feedback from @Google Gemini after receiving a SAIMSARA evidence snippet.
The pattern is becoming clear: general AI answers are often reasonable — but SAIMSARA makes them more precise, clinical, and evidence-grounded.
We give your LLM the evidence layer it actually needs.
SAIMSARA — evidence your AI will appreciate.
#SAIMSARA #GoogleGemini #AI #LLM #RAG #MedicalAI #EvidenceBasedMedicine
We are launching the SAIMSARA 🅴🆅🅸🅳🅴🅽🅲🅴 API — built to give life-science and medical AI systems a stronger, faster, and more traceable evidence layer.
For many workflows, the problem is no longer:
“𝑊ℎ𝑖𝑐ℎ 𝑚𝑜𝑑𝑒𝑙 𝑖𝑠 𝑠𝑚𝑎𝑟𝑡𝑒𝑠𝑡?”
The real question is:
“𝑊ℎ𝑎𝑡 𝑒𝑣𝑖𝑑𝑒𝑛𝑐𝑒 𝑖𝑠 𝑡ℎ𝑒 𝑚𝑜𝑑𝑒𝑙 𝑎𝑙𝑙𝑜𝑤𝑒𝑑 𝑡𝑜 𝑡ℎ𝑖𝑛𝑘 𝑤𝑖𝑡ℎ?”
The SAIMSARA database gives external AI/RAG systems access to large-scale scoping-review evidence objects: searchable, citable, fast to retrieve, and designed for integration into research, clinical-support, and educational AI workflows.
Each evidence object is generated from large scientific literature retrieval sessions — often hundreds to thousands of source references — and human-reviewed.
Limited API access is now available for subscribers, with business-level access planned for teams building serious scientific AI systems.
Connect your LLM to structured evidence — and see what happens to its performance.
https://t.co/MvK6cNO9tw
#SAIMSARA #EvidenceAPI #RAG #GenerativeAI #MedicalAI #LifeSciences #ClinicalAI #ResearchAI #EvidenceBasedMedicine #ScientificAI #HealthTech #MedTech #ArtificialIntelligence